TOKYO, Mar 10 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported the massive exercise of warrant options issued on January 5, 2026.
As of March 10, 2026, a total of 5,000 warrants were exercised, resulting in the issuance of 500,000 shares. Prior to this exercise, there were 19,299 unexercised warrants out of a total of 36,800 issued warrants, representing a ratio of 13.59%. At the time of the previous disclosure, the number of unexercised warrants was 500,000 and now stands at 14,299.
The exercise price for these warrants was adjusted according to the closing price on the trading day of December 17, 2025, which was set at March 10, 2026. This adjustment allowed for the exercise price to exceed the limitations imposed by the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association's Rules on Third-Party Allotment Increases. The company noted that the detailed information regarding the issuance of these warrant options can be found in the announcement published on December 17, 2025.
🟡 Confidence: Standard AI-translated content.